Table 2.
Logistic regression analysis of the association between the risk of CHD and Hsp70 and anti-Hsp70 antibody levels
| Variable | ACS + SA | ACS | SA | |||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Age ≥ 60y | 1.56 | 1.09-2.24 | 1.67 | 1.10-2.54 | 1.51 | 0.90-2.54 |
| Male | 0.92 | 0.61-1.38 | 0.91 | 0.57-1.44 | 1.14 | 0.66-1.96 |
| Smoking | 1.52 | 1.02-2.26 | 1.42 | 0.91-2.22 | 1.88 | 1.03-3.42 |
| BMI | 0.96 | 0.91-1.01 | 0.97 | 0.91-1.03 | 0.94 | 0.87-1.02 |
| Hypercholesterolemia | 0.81 | 0.58-1.14 | 0.81 | 0.56-1.19 | 0.86 | 0.53-1.40 |
| Hypertension | 5.34 | 3.78-7.56 | 5.76 | 3.87-8.58 | 5.02 | 3.02-8.35 |
| Diabetes | 5.31 | 3.28-8.61 | 5.21 | 3.10-8.78 | 5.58 | 3.06-10.15 |
| Family history of CHD | 6.97 | 3.10-15.70 | 7.87 | 3.30-18.77 | 6.60 | 2.38-18.27 |
| High Hsp70 (ng/mL) | 2.07 | 1.50-2.86 | 2.41 | 1.68-3.45 | 1.36 | 0.86-2.17 |
| High anti-Hsp70 antibody (µg/mL) | 0.61 | 0.44-0.84 | 0.49 | 0.34-0.70 | 0.89 | 0.56-1.41 |
High Hsp70 Hsp70 level > median; high anti-Hsp70 antibody anti-Hsp70 antibody level > median